Wednesday, June 10, 2026
🇺🇸 FDA

P0 · Therapeutic area intelligence

Infectious disease patent intelligence

Antiviral, antibacterial, and vaccine-related pharmaceutical patents.

Patents
1,492

Quick answer

1,492 US pharmaceutical patents in our index match Infectious disease title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 6017880

    Inhibition of retrovirus infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6015832

    Methods of inactivating bacteria including bacterial spores

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6015660

    Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases

    The Regents of the University of California · Granted Tue Jan 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6015882

    Vaccines, antibodies, proteins, glycoproteins, DNAs and RNAs for prophylaxis and treatment of Cryptosporidium parvum infections

    The Regents of the University of California · Granted Tue Jan 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many Infectious disease patents are indexed?

1,492 patents match our Infectious disease classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.